Bluebird Bio reported $160.44M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Amgen AMGN:US USD 24.06B 4.74B
Arrowhead Research ARWR:US USD 405.3M 27.09M
Avrobio Inc AVRO:US USD 126.23M 15.85M
Biogen BIIB:US USD 9.77B 24.9M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Gilead Sciences GILD:US USD 13.55B 379M
Immunogen IMGN:US USD 330.42M 63.51M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
IONIS PHARMACEUT IONS:US USD 2.15B 39.02M
Mirati Therapeutics MRTX:US USD 1.23B 22.86M
Moderna Inc MRNA:US USD 14.3B 734M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Novartis NOVN:VX USD 36.95B 1.19B
Pfizer PFE:US USD 70.4B 2.94B
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Sangamo Biosciences SGMO:US USD 336.62M 6.5M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Seattle Genetics SGEN:US USD 2.76B 19.04M
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
YTE INCY:US USD 3.82B 195.27M